Review: taking Losartan and Spironolactone together


Summary

Drug interactions are reported among people who take Losartan and Spironolactone together. This review analyzes the effectiveness and drug interactions between Losartan and Spironolactone. It is created by eHealthMe based on reports of 3,287 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Losartan

Losartan has active ingredients of losartan potassium. It is often used in high blood pressure. (latest outcomes from Losartan 45,459 users)

Spironolactone

Spironolactone has active ingredients of spironolactone. It is often used in high blood pressure. (latest outcomes from Spironolactone 41,317 users)

On Sep, 16, 2016

3,287 people who take Losartan, Spironolactone are studied.


Number of reports submitted per year:

Losartan and Spironolactone drug interactions.

Drug effectiveness over time:

Losartan:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 62.0% - (5 of 8 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 40.0% - (2 of 5 people)
  • 2 - 5 years: 14.0% - (1 of 7 people)
  • 5 - 10 years: 57.0% - (4 of 7 people)
  • 10+ years: 66.0% - (2 of 3 people)
  • not specified: 0.0% - (0 of 0 people)
Spironolactone:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 50.0% - (3 of 6 people)
  • 6 - 12 months: 50.0% - (2 of 4 people)
  • 1 - 2 years: 33.0% - (2 of 6 people)
  • 2 - 5 years: 0.0% - (0 of 6 people)
  • 5 - 10 years: 50.0% - (2 of 4 people)
  • 10+ years: 100.0% - (2 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Losartan:
  • female: 44.0% - (8 of 18 people)
  • male: 42.0% - (6 of 14 people)
Spironolactone:
  • female: 47.0% - (8 of 17 people)
  • male: 25.0% - (3 of 12 people)

Drug effectiveness by age:

Losartan:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 100.0% - (5 of 5 people)
  • 50-59: 60.0% - (3 of 5 people)
  • 60+: 30.0% - (6 of 20 people)
Spironolactone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 75.0% - (3 of 4 people)
  • 50-59: 25.0% - (1 of 4 people)
  • 60+: 36.0% - (7 of 19 people)

Most common drug interactions over time *:

< 1 month:
  • hyperkalaemia
  • renal failure acute
  • blood creatinine increased
  • nephrotic syndrome
  • blood urea increased
  • cardiac arrest
  • renal failure chronic
  • cardiac failure
  • hypotension
  • international normalised ratio increased
1 - 6 months:
  • hyperkalaemia
  • renal failure acute
  • anaemia
  • blood urea increased
  • chest pain
  • dizziness
  • atrioventricular block
  • cardiac arrest
  • blood creatinine increased
  • fatigue
6 - 12 months:
  • hyperkalaemia
  • asthenia
  • urinary tract infection
  • general physical health deterioration
  • renal failure acute
  • anorexia
  • sepsis
  • blood potassium decreased
  • bronchiectasis
  • dehydration
1 - 2 years:
  • acid reflux
  • allergies
  • gouty arthritis
  • high blood pressure
  • anaemia
  • cardiac failure
  • chest pain
  • international normalised ratio increased
  • death
  • dehydration
2 - 5 years:
  • hyperkalaemia
  • hyponatraemia
  • dementia
  • palpitations
  • renal failure acute
  • cardiac failure
  • ascites
  • breath sounds abnormal
  • cardiac arrest
  • cardiogenic shock
5 - 10 years:
  • anaemia
  • eczema
  • sensitivity of teeth
  • xerosis
  • blood immunoglobulin e increased
  • bradycardia
  • cardiac disorder
  • cerebrovascular accident
  • eosinophil count increased
  • eosinophilic pneumonia
10+ years:
  • bradycardia
  • electrolyte imbalance
  • hyperkalaemia
  • syncope
  • electrocardiogram t wave abnormal
  • nodal rhythm
  • presyncope
  • blood potassium increased
  • electrocardiogram t wave peaked
  • memory impairment
not specified:
  • dyspnoea
  • fatigue
  • dizziness
  • pain
  • cardiac failure congestive
  • asthenia
  • nausea
  • fall
  • hypertension
  • diarrhoea

Most common drug interactions by gender *:

female:
  • dyspnoea
  • fatigue
  • pain
  • diarrhoea
  • hypertension
  • dizziness
  • cardiac failure congestive
  • asthenia
  • nausea
  • pneumonia
male:
  • dyspnoea
  • chest pain
  • cardiac failure congestive
  • fatigue
  • cough
  • dizziness
  • anaemia
  • pain
  • asthenia
  • hyperkalaemia

Most common drug interactions by age *:

0-1:
  • pulmonary embolism
  • proteinuria
  • seizure
  • haemolytic uraemic syndrome
  • blood pressure decreased
  • nephrotic syndrome
  • renal failure acute
  • abdominal mass
  • abdominal pain
  • cerebrovascular disorder
2-9:
  • pyrexia
  • renal failure acute
  • blood pressure systolic decreased
  • cyanosis
  • device related infection
  • hypotension
  • pneumonia
  • respiratory syncytial virus infection
  • pharyngitis streptococcal
  • appendicitis
10-19:
  • blood alkaline phosphatase increased
  • blood lactate dehydrogenase increased
  • blood urea increased
  • dyspnoea
  • hypogammaglobulinaemia
  • lung infiltration
  • pulmonary haemorrhage
  • pyrexia
  • renal failure acute
  • arthralgia
20-29:
  • anaemia
  • cardiac failure congestive
  • nausea
  • international normalised ratio increased
  • oedema
  • blood creatine phosphokinase increased
  • excessive eye blinking
  • gastroenteritis
  • headache
  • hyperlipidaemia
30-39:
  • pain
  • cardiac failure congestive
  • fatigue
  • abdominal distension
  • anxiety
  • weight increased
  • cough
  • feeling abnormal
  • dyspnoea
  • anhedonia
40-49:
  • oedema peripheral
  • fatigue
  • abdominal distension
  • urinary tract infection
  • fall
  • pain
  • chest pain
  • dizziness
  • back pain
  • constipation
50-59:
  • dyspnoea
  • fatigue
  • cardiac failure congestive
  • chest pain
  • pain
  • hypertension
  • pain in extremity
  • diarrhoea
  • dizziness
  • anxiety
60+:
  • dyspnoea
  • asthenia
  • hyperkalaemia
  • dizziness
  • cardiac failure congestive
  • pain
  • fatigue
  • fall
  • diarrhoea
  • anaemia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Losartan and Spironolactone?

Can you answer these questions?

More questions for: Losartan, Spironolactone

You may be interested in these reviews

More reviews for: Losartan, Spironolactone

On eHealthMe, Losartan (losartan potassium) is often used to treat high blood pressure. Spironolactone (spironolactone) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.